Tiziana Life Sciences
TLSA
6 hedge funds and large institutions have $4.34M invested in Tiziana Life Sciences in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
76% more capital inflows, than outflows
Capital inflows: $63.2K | Capital outflows: $35.9K
20% more funds holding
Funds holding: 5 → 6 (+1)
0.03% more ownership
Funds ownership: 3.18% → 3.21% (+0.03%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$34.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$28.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$33.9K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2K |
TLSA Hedge Fund Activity: Q4 2019 in Review
6 of the 5,094 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q4 2019, worth a combined $4.34M — up 3.7% from $4.18M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TLSA positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Barclays, opening a new position worth an estimated $34.4K. The largest seller was HighPoint Advisor Group, cutting an estimated $33.9K.
- 6 institutional investors held Tiziana Life Sciences (TLSA) as of Q4 2019, up from 5 in Q3 2019.
- Funds reported $4.34M of Tiziana Life Sciences stock for Q4 2019, up 3.7% quarter-over-quarter.
- 2 funds opened new Tiziana Life Sciences positions in Q4 2019 and 1 closed out, a net change of +1 holder.
- The largest Tiziana Life Sciences buyer in Q4 2019 was Barclays, an estimated $34.4K added.
- The largest Tiziana Life Sciences seller in Q4 2019 was HighPoint Advisor Group, an estimated $33.9K sold.
Based on aggregated 13F filings for Q4 2019.